PACS Group Inc. (PACS)
NYSE: PACSHealth CareHospital/Nursing ManagementUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PACS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $6.93B
- P/E (TTM)
- 24.81
- Forward P/E
- 15.30
- EPS (TTM)
- $1.76
- Dividend yield
- None
- 52-week range
- 27.37 – 51.68
- Day range
- 42.84 – 44.36
- Volume / Avg
- 964.37K / 809.18K
- Beta
- —
- Shares outstanding
- 158.72M
52-week range
PACS stock today
PACS Group (PACS) closed at $43.67 on Nov 20, up 1.49% (+$0.64), versus the S&P 500's 3.70% decline. Shares are 15.5% below their 52-week high of $51.68, set on Nov 4, 2026 and 59.6% above the 52-week low of $27.37, in the middle of the past year's range. PACS is up 13.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 58.8%.
At 24.8x trailing earnings, PACS Group trades above the peer-group median of 16.6x. Its forward P/E of 15.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About PACS Group
Company profilePACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties.
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- CEO
- Mr. Jason Murray
- Headquarters
- Salt Lake City, UT
- Employees
- 47,455
- IPO year
- 2024
- Website
- pacs.com
Financial highlights
Full financialsIn fiscal 2025, PACS Group generated $5.29 billion in revenue, up 29.3% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $191.5 million (+243.5% year over year), for a net margin of 3.6% versus a median of 3.6% in the prior 3 years. Gross margin was 21.9% (up from 19.4%) and operating margin 5.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $3.11B | $2.42B |
| Growth | +29.32% | +31.44% | +28.47% | — |
| Net income | $191.54M | $55.76M | $112.87M | $150.50M |
| EPS (diluted) | $1.22 | $0.38 | $0.88 | $1.17 |
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$62.50+43.12%
- Strong buy 2
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $0.37 vs $0.56
- Surprise
- -33.93%
PACS news
All PACS news- Noteworthy Thursday Option Activity: SNDK, PACS, ZMNasdaqSNDK, PACS, ZM, BF.A
- Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR Newswire
- PACS raises 2026 outlook to $5.95B-$6.05B revenue and $685M-$695M adjusted EBITDA amid Florida entrySeeking Alpha
- Crypto PACs eye 2028 “new map” as Democrats take CongressCointelegraph
- Why is PACS stock surging today?Investing.com
- PACS Group, Inc. Reports Third Quarter 2026 ResultsBusiness Wire
- ‘Pop-up’ super PACs pour $637 million into 2026 midterm racesCNBC
- PACS Group Schedules Third Quarter 2026 Earnings Release and Conference CallBusiness Wire
PACS Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SGRYSurgery Partners Inc. | 26.78 | +0.34% | $3.50B | vs PACS |
| ENSGThe Ensign Group Inc. | 176.32 | -0.15% | $10.29B | vs PACS |
| UHSUniversal Health Services Inc. | 179.43 | +2.54% | $10.34B | vs PACS |
| NHCNational HealthCare Corporation | 190.77 | +1.18% | $2.99B | vs PACS |
| MDPediatrix Medical Group Inc. | 30.22 | +0.94% | $2.36B | vs PACS |
| BKDBrookdale Senior Living Inc. | 8.86 | +1.96% | $2.12B | vs PACS |
| ARDTArdent Health Inc. | 15.08 | +4.00% | $2.10B | vs PACS |
| HCSGHealthcare Services Group Inc. | 24.72 | -0.20% | $1.67B | vs PACS |
Indexes, lists and sector
PACS Group stock FAQ
What is PACS Group's stock price today?
PACS last traded at $43.67 as of Nov 20, 4:00 PM EST, up 1.49% on the day. Prices are delayed at least 15 minutes.
What is PACS's P/E ratio?
PACS trades at a trailing P/E ratio of 24.81 and a forward P/E of 15.30, compared with a median of 16.6 for its closest peers.
Who is PACS Group's CEO?
Mr. Jason Murray is the chief executive officer of PACS Group Inc., which has about 47,455 employees.
What is the PACS 52-week high?
The 52-week high for PACS is $51.68 and the 52-week low is $27.37. The stock is currently 15.5% below its high.